Full Text View
Tabular View
No Study Results Posted
Related Studies
Butylphthalide for Preventing Restenosis After Intracranial and Extracranial Artery Stenting (BPRIAS)
This study is currently recruiting participants.
Verified June 2012 by Jinling Hospital, China
Study NCT01405248   Information provided by Jinling Hospital, China

First Received on July 28, 2011.   Last Updated on June 10, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Restenosis
Interventions listed in this trial
Butylphthalide
Additional drug interventions recognized in this trial
3-n-butylphthalide
More general drug interventions related to this trial
Central Nervous System Agents
Neuroprotective Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Jinling Hospital, China
CSPC-NBP Pharmaceutical Co., Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services